John H. Sampson, MD, PhD, was formerly inducted into the National Academy of Medicine at the annual meeting on October 13, 2018, in Washington, D.C.
Sampson is the Robert H. and Gloria Wilkins Distinguished Professor and Chair of the Department of Neurosurgery at Duke University as well as the Co-Leader of the Duke Cancer Institute’s Neuro-Oncology Program. He is a neurosurgeon-scientist who develops novel drugs for patients with brain tumors and focuses on the development, translation, and mechanistic understanding of immunotherapies.
His clinical practice is focused on treating patients with both benign and malignant brain tumors, and his research laboratory is actively investigating new modalities of direct brain tumor infusion and immunotherapy. He has been continuously funded by the NIH for 20 years.
Sampson has published more than 200 peer-reviewed articles in journals such as Nature, JAMA, and the Proceedings of the National Academy of Sciences, and has been an editorial board member for all major journals in the field.
In addition to membership in the National Academy of Medicine, Sampson is a member of the Association of American Physicians. In April 2018 he was elected president of the Private Diagnostic Clinic, Duke’s physician practice with 1,650 members and $865 million annual total revenue.
Founded in 1970, the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States. The National Academies are private, nonprofit institutions that work outside of government to provide objective advice on matters of science, technology, and health. The mission of NAM is to improve health for all by advancing science, accelerating health equity, and providing independent, authoritative, and trusted advice nationally and globally.